Is the UK's 2017 drug strategy fit for purpose?

Ford, Chris; Nutt, David; Eastwood, Niamh; Gold, Deborah; Jolly, John; Murphy, Fionnuala; Halliday, Kate; Bridge, Jamie

Ford, Chris; Nutt, David; Eastwood, Niamh; Gold, Deborah; Jolly, John; Murphy, Fionnuala; Halliday, Kate; Bridge, Jamie.

Afiliação

Ford C; International Doctors for Healthier Drug Policies, London NW1 0JH, UK.
Nutt D; Drug Science, London SW8 1GB, UK.
Eastwood N; Release, London EC1V 2NJ, UK.
Gold D; National AIDS Trust, London EC1V 9FR, UK.
Jolly J; Blenheim CDP, London SW8 2JU, UK.
Murphy F; Harm Reduction International, London SE1 6LN, UK.
Halliday K; Substance Misuse Management Good Practice (SMMGP), Box 200, London SW19 1LJ, UK.
Bridge J; International Drug Policy Consortium, London EC1V 2NJ, UK.

BMJ ; 358: j4405, 2017 09 29.

Article em En | MEDLINE | ID: mdl-28963111

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: BMJ Assunto da revista: MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google